Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Ultraviolet B-induced Otx2 expression in lens epithelial cells promotes epithelial-mesenchymal transition.

Yoshitomi Y, Osada H, Satake H, Kojima M, Saito-Takatsuji H, Ikeda T, Yoshitake Y, Ishigaki Y, Kubo E, Sasaki H, Yonekura H.

Biol Open. 2019 Feb 18;8(2). pii: bio035691. doi: 10.1242/bio.035691.

2.

Utilization of arterial pulse waveform analysis during non-cardiac surgery in Japan: a retrospective observational study using a nationwide claims database.

Takeda C, Takeuchi M, Mizota T, Yonekura H, Nahara I, Kuwauchi A, Joo WJ, Kawasaki Y, Kawakami K.

J Anesth. 2019 Feb;33(1):159-162. doi: 10.1007/s00540-018-02609-x. Epub 2019 Jan 7.

PMID:
30617547
3.

Prophylactic sivelestat for esophagectomy and in-hospital mortality: a propensity score-matched analysis of claims database.

Takeda C, Takeuchi M, Kawasaki Y, Yonekura H, Nahara I, Kuwauchi A, Yoshida S, Tanaka S, Kawakami K.

J Anesth. 2019 Apr;33(2):230-237. doi: 10.1007/s00540-018-2602-9. Epub 2019 Jan 5.

PMID:
30612210
4.

Preoperative Echocardiography for Patients With Hip Fractures Undergoing Surgery: A Retrospective Cohort Study Using a Nationwide Database.

Yonekura H, Ide K, Onishi Y, Nahara I, Takeda C, Kawakami K.

Anesth Analg. 2019 Feb;128(2):213-220. doi: 10.1213/ANE.0000000000003888.

PMID:
30379676
5.

Influence of Institution-Based Factors on Preoperative Blood Testing Prior to Low-Risk Surgery: A Bayesian Generalized Linear Mixed Approach.

Ide K, Yonekura H, Kawasaki Y, Kawakami K.

Comput Math Methods Med. 2017;2017:3624075. doi: 10.1155/2017/3624075. Epub 2017 Dec 7.

6.

Preoperative Blood Tests Conducted Before Low-Risk Surgery in Japan: A Retrospective Observational Study Using a Nationwide Insurance Claims Database.

Yonekura H, Seto K, Ide K, Kawasaki Y, Tanaka S, Nahara I, Takeda C, Kawakami K.

Anesth Analg. 2018 May;126(5):1633-1640. doi: 10.1213/ANE.0000000000002734.

PMID:
29256933
7.

Preoperative pulmonary function tests before low-risk surgery in Japan: a retrospective cohort study using a claims database.

Yonekura H, Ide K, Seto K, Kawasaki Y, Tanaka S, Nahara I, Takeda C, Kawakami K.

J Anesth. 2018 Feb;32(1):23-32. doi: 10.1007/s00540-017-2423-2. Epub 2017 Nov 4.

PMID:
29103149
8.

The Usefulness of Virtual Fluoroscopic Preprocedural Planning During Percutaneous Transhepatic Biliary Drainage.

Kinoshita M, Shirono R, Takechi K, Yonekura H, Iwamoto S, Shinya T, Takao S, Harada M.

Cardiovasc Intervent Radiol. 2017 Jun;40(6):894-901. doi: 10.1007/s00270-017-1581-9. Epub 2017 Jan 26.

PMID:
28127630
9.

JunB regulates angiogenesis and neurovascular parallel alignment in mouse embryonic skin.

Yoshitomi Y, Ikeda T, Saito H, Yoshitake Y, Ishigaki Y, Hatta T, Kato N, Yonekura H.

J Cell Sci. 2017 Mar 1;130(5):916-926. doi: 10.1242/jcs.196303. Epub 2017 Jan 17.

10.

Comparison of anesthetic management and outcomes of robot-assisted vs pure laparoscopic radical prostatectomy.

Yonekura H, Hirate H, Sobue K.

J Clin Anesth. 2016 Dec;35:281-286. doi: 10.1016/j.jclinane.2016.08.014. Epub 2016 Oct 10.

PMID:
27871544
11.

A Case of Delayed Emergence After Propofol Anesthesia: Genetic Analysis.

Yonekura H, Murayama N, Yamazaki H, Sobue K.

A A Case Rep. 2016 Dec 1;7(11):243-246.

PMID:
27749294
12.

Effect of Collagen Tripeptide on Atherosclerosis in Healthy Humans.

Tomosugi N, Yamamoto S, Takeuchi M, Yonekura H, Ishigaki Y, Numata N, Katsuda S, Sakai Y.

J Atheroscler Thromb. 2017 May 1;24(5):530-538. doi: 10.5551/jat.36293. Epub 2016 Oct 6.

13.

Oxide-Oxide Thermocompression Direct Bonding Technologies with Capillary Self-Assembly for Multichip-to-Wafer Heterogeneous 3D System Integration.

Fukushima T, Hashiguchi H, Yonekura H, Kino H, Murugesan M, Bea JC, Lee KW, Tanaka T, Koyanagi M.

Micromachines (Basel). 2016 Oct 10;7(10). pii: E184. doi: 10.3390/mi7100184.

14.

Regulation of soluble Flt-1 (VEGFR-1) production by hnRNP D and protein arginine methylation.

Ikeda T, Yoshitomi Y, Saito H, Shimasaki T, Yamaya H, Kobata T, Ishigaki Y, Tomosugi N, Yoshitake Y, Yonekura H.

Mol Cell Biochem. 2016 Feb;413(1-2):155-64. doi: 10.1007/s11010-015-2649-y. Epub 2016 Jan 4.

PMID:
26728997
15.

[Incidence, Risk Factors, and Effects on Outcome of Postoperative Delirium in Patients Undergoing Esophagectomy].

Yonekura H, Hirate H, Sobue K.

Masui. 2015 Jun;64(6):597-602. Japanese.

PMID:
26437547
16.

Melanocortins contribute to sequential differentiation and enucleation of human erythroblasts via melanocortin receptors 1, 2 and 5.

Simamura E, Arikawa T, Ikeda T, Shimada H, Shoji H, Masuta H, Nakajima Y, Otani H, Yonekura H, Hatta T.

PLoS One. 2015 Apr 10;10(4):e0123232. doi: 10.1371/journal.pone.0123232. eCollection 2015.

17.

Partially unroofed coronary sinus with persistent left superior vena cava: the utility of two and three-dimensional transesophageal echocardiography: a case report.

Yonekura H, Kanazawa S, Miyawaki I, Yamazaki K.

Korean J Anesthesiol. 2014 Jul;67(1):52-6. doi: 10.4097/kjae.2014.67.1.52. Epub 2014 Jul 29.

18.

Osteocytic cell necrosis is caused by a combination of glucocorticoid-induced Dickkopf-1 and hypoxia.

Ueda S, Ichiseki T, Yoshitomi Y, Yonekura H, Ueda Y, Kaneuji A, Matsumoto T.

Med Mol Morphol. 2015 Jun;48(2):69-75. doi: 10.1007/s00795-014-0077-9. Epub 2014 May 13.

PMID:
24819581
19.

Low-molecular weight fractions of Japanese soy sauce act as a RAGE antagonist via inhibition of RAGE trafficking to lipid rafts.

Munesue S, Yamamoto Y, Urushihara R, Inomata K, Saito H, Motoyoshi S, Watanabe T, Yonekura H, Yamamoto H.

Food Funct. 2013 Dec;4(12):1835-42. doi: 10.1039/c2fo30359k.

PMID:
24191276
20.

Effects of 25-hydroxy-cholecalciferol on the development of osteochondrosis in swine.

Sugiyama T, Kusuhara S, Chung TK, Yonekura H, Azem E, Hayakawa T.

Anim Sci J. 2013 Apr;84(4):341-9. doi: 10.1111/asj.12000. Epub 2012 Nov 19.

PMID:
23590509
21.

Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells.

Takeuchi A, Yamamoto Y, Munesue S, Harashima A, Watanabe T, Yonekura H, Yamamoto H, Tsuchiya H.

Cancer Sci. 2013 Jun;104(6):740-9. doi: 10.1111/cas.12133. Epub 2013 Mar 24.

22.

Loss of HITS (FAM107B) expression in cancers of multiple organs: tissue microarray analysis.

Nakajima H, Koizumi K, Tanaka T, Ishigaki Y, Yoshitake Y, Yonekura H, Sakuma T, Fukushima T, Umehara H, Ueno S, Minamoto T, Motoo Y.

Int J Oncol. 2012 Oct;41(4):1347-57. doi: 10.3892/ijo.2012.1550. Epub 2012 Jul 10.

PMID:
22825356
23.

Identification of a major enzyme for the synthesis and hydrolysis of cyclic ADP-ribose in amphibian cells and evolutional conservation of the enzyme from human to invertebrate.

Ikeda T, Takasawa S, Noguchi N, Nata K, Yamauchi A, Takahashi I, Yoshikawa T, Sugawara A, Yonekura H, Okamoto H.

Mol Cell Biochem. 2012 Jul;366(1-2):69-80. doi: 10.1007/s11010-012-1284-0. Epub 2012 Mar 16.

PMID:
22422046
24.

Endogenous secretory receptor for advanced glycation end-products inhibits amyloid-β1-42 uptake into mouse brain.

Sugihara T, Munesue S, Yamamoto Y, Sakurai S, Akhter N, Kitamura Y, Shiba K, Watanabe T, Yonekura H, Hayashi Y, Hamada J, Yamamoto H.

J Alzheimers Dis. 2012;28(3):709-20. doi: 10.3233/JAD-2011-110776.

PMID:
22064071
25.

Suppression of a neocortical potassium channel activity by intracellular amyloid-β and its rescue with Homer1a.

Yamamoto K, Ueta Y, Wang L, Yamamoto R, Inoue N, Inokuchi K, Aiba A, Yonekura H, Kato N.

J Neurosci. 2011 Aug 3;31(31):11100-9. doi: 10.1523/JNEUROSCI.6752-10.2011.

26.

Hypoxia down-regulates sFlt-1 (sVEGFR-1) expression in human microvascular endothelial cells by a mechanism involving mRNA alternative processing.

Ikeda T, Sun L, Tsuruoka N, Ishigaki Y, Yoshitomi Y, Yoshitake Y, Yonekura H.

Biochem J. 2011 Jun 1;436(2):399-407. doi: 10.1042/BJ20101490.

27.

Septic shock is associated with receptor for advanced glycation end products ligation of LPS.

Yamamoto Y, Harashima A, Saito H, Tsuneyama K, Munesue S, Motoyoshi S, Han D, Watanabe T, Asano M, Takasawa S, Okamoto H, Shimura S, Karasawa T, Yonekura H, Yamamoto H.

J Immunol. 2011 Mar 1;186(5):3248-57. doi: 10.4049/jimmunol.1002253. Epub 2011 Jan 26.

28.

Ultraviolet B-induced expression of amphiregulin and growth differentiation factor 15 in human lens epithelial cells.

Osada H, Yoshitake Y, Ikeda T, Ishigaki Y, Takata T, Tomosugi N, Sasaki H, Yonekura H.

Mol Vis. 2011 Jan 13;17:159-69.

29.

Identification of the COL2A1 mutation in patients with type I Stickler syndrome using RNA from freshly isolated peripheral white blood cells.

Yaguchi H, Ikeda T, Osada H, Yoshitake Y, Sasaki H, Yonekura H.

Genet Test Mol Biomarkers. 2011 Apr;15(4):231-7. doi: 10.1089/gtmb.2010.0138. Epub 2010 Dec 27.

PMID:
21186996
30.

Induction of HITS, a newly identified family with sequence similarity 107 protein (FAM107B), in cancer cells by heat shock stimulation.

Nakajima H, Ishigaki Y, Xia QS, Ikeda T, Yoshitake Y, Yonekura H, Nojima T, Tanaka T, Umehara H, Tomosugi N, Takata T, Shimasaki T, Nakaya N, Sato I, Kawakami K, Koizumi K, Minamoto T, Motoo Y.

Int J Oncol. 2010 Sep;37(3):583-93.

PMID:
20664927
31.

Two kinesin-like proteins mediate actin-based chloroplast movement in Arabidopsis thaliana.

Suetsugu N, Yamada N, Kagawa T, Yonekura H, Uyeda TQ, Kadota A, Wada M.

Proc Natl Acad Sci U S A. 2010 May 11;107(19):8860-5. doi: 10.1073/pnas.0912773107. Epub 2010 Apr 23.

32.

Regulation of alternative splicing of the receptor for advanced glycation endproducts (RAGE) through G-rich cis-elements and heterogenous nuclear ribonucleoprotein H.

Ohe K, Watanabe T, Harada S, Munesue S, Yamamoto Y, Yonekura H, Yamamoto H.

J Biochem. 2010 May;147(5):651-9. doi: 10.1093/jb/mvp207. Epub 2009 Dec 21.

PMID:
20028692
33.

Solution structure of the variable-type domain of the receptor for advanced glycation end products: new insight into AGE-RAGE interaction.

Matsumoto S, Yoshida T, Murata H, Harada S, Fujita N, Nakamura S, Yamamoto Y, Watanabe T, Yonekura H, Yamamoto H, Ohkubo T, Kobayashi Y.

Biochemistry. 2008 Nov 25;47(47):12299-311. doi: 10.1021/bi800910v.

PMID:
19032093
34.

Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains.

Nozaki I, Watanabe T, Kawaguchi M, Akatsu H, Tsuneyama K, Yamamoto Y, Ohe K, Yonekura H, Yamada M, Yamamoto H.

Arch Histol Cytol. 2007 Dec;70(5):279-90.

35.

RAGE in diabetic nephropathy.

Yamamoto H, Watanabe T, Yamamoto Y, Yonekura H, Munesue S, Harashima A, Ooe K, Hossain S, Saito H, Murakami N.

Curr Mol Med. 2007 Dec;7(8):752-7. Review.

PMID:
18331233
36.

Promotion by collagen tripeptide of type I collagen gene expression in human osteoblastic cells and fracture healing of rat femur.

Tsuruoka N, Yamato R, Sakai Y, Yoshitake Y, Yonekura H.

Biosci Biotechnol Biochem. 2007 Nov;71(11):2680-7. Epub 2007 Nov 7.

37.

De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts.

Osawa M, Yamamoto Y, Munesue S, Murakami N, Sakurai S, Watanabe T, Yonekura H, Uchigata Y, Iwamoto Y, Yamamoto H.

Biochim Biophys Acta. 2007 Oct;1770(10):1468-74. Epub 2007 Jul 19.

PMID:
17714874
38.

Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.

Takeuchi A, Yamamoto Y, Tsuneyama K, Cheng C, Yonekura H, Watanabe T, Shimizu K, Tomita K, Yamamoto H, Tsuchiya H.

Cancer. 2007 Jun 15;109(12):2532-40.

39.

Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells.

Yamamoto Y, Yonekura H, Watanabe T, Sakurai S, Li H, Harashima A, Myint KM, Osawa M, Takeuchi A, Takeuchi M, Yamamoto H.

Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S30-40. Epub 2007 Apr 25.

PMID:
17462779
40.

Endogenous secretory receptor for advanced glycation endproducts levels are correlated with serum pentosidine and CML in patients with type 1 diabetes.

Miura J, Yamamoto Y, Osawa M, Watanabe T, Yonekura H, Uchigata Y, Yamamoto H, Iwamoto Y.

Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):253-4. No abstract available.

PMID:
17185626
41.

RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.

Myint KM, Yamamoto Y, Doi T, Kato I, Harashima A, Yonekura H, Watanabe T, Shinohara H, Takeuchi M, Tsuneyama K, Hashimoto N, Asano M, Takasawa S, Okamoto H, Yamamoto H.

Diabetes. 2006 Sep;55(9):2510-22.

42.

Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.

Shoji T, Koyama H, Morioka T, Tanaka S, Kizu A, Motoyama K, Mori K, Fukumoto S, Shioi A, Shimogaito N, Takeuchi M, Yamamoto Y, Yonekura H, Yamamoto H, Nishizawa Y.

Diabetes. 2006 Aug;55(8):2245-55.

43.

Mechanism of tail-mediated inhibition of kinesin activities studied using synthetic peptides.

Yonekura H, Nomura A, Ozawa H, Tatsu Y, Yumoto N, Uyeda TQ.

Biochem Biophys Res Commun. 2006 May 5;343(2):420-7. Epub 2006 Mar 9.

PMID:
16546134
44.

Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.

Harashima A, Yamamoto Y, Cheng C, Tsuneyama K, Myint KM, Takeuchi A, Yoshimura K, Li H, Watanabe T, Takasawa S, Okamoto H, Yonekura H, Yamamoto H.

Biochem J. 2006 May 15;396(1):109-15.

45.

Development of an ELISA for esRAGE and its application to type 1 diabetic patients.

Sakurai S, Yamamoto Y, Tamei H, Matsuki H, Obata K, Hui L, Miura J, Osawa M, Uchigata Y, Iwamoto Y, Watanabe T, Yonekura H, Yamamoto H.

Diabetes Res Clin Pract. 2006 Aug;73(2):158-65. Epub 2006 Feb 20.

PMID:
16488505
46.

Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis.

Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, Emoto M, Shoji T, Tamei H, Matsuki H, Sakurai S, Yamamoto Y, Yonekura H, Watanabe T, Yamamoto H, Nishizawa Y.

Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2587-93. Epub 2005 Oct 13.

PMID:
16224056
47.

Receptor for advanced glycation end products is a promising target of diabetic nephropathy.

Yamamoto Y, Doi T, Kato I, Shinohara H, Sakurai S, Yonekura H, Watanabe T, Myint KM, Harashima A, Takeuchi M, Takasawa S, Okamoto H, Hashimoto N, Asano M, Yamamoto H.

Ann N Y Acad Sci. 2005 Jun;1043:562-6.

PMID:
16037279
48.

Blockade of diabetic vascular injury by controlling of AGE-RAGE system.

Myint KM, Yamamoto Y, Sakurai S, Harashima A, Watanabe T, Li H, Takeuchi A, Yoshimura K, Yonekura H, Yamamoto H.

Curr Drug Targets. 2005 Jun;6(4):447-52. Review.

PMID:
16026264
49.

Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs.

Cheng C, Tsuneyama K, Kominami R, Shinohara H, Sakurai S, Yonekura H, Watanabe T, Takano Y, Yamamoto H, Yamamoto Y.

Mod Pathol. 2005 Oct;18(10):1385-96.

50.

Possible participation of pICln in the regulation of angiogenesis through alternative splicing of vascular endothelial growth factor receptor mRNAs.

Li H, Yonekura H, Kim CH, Sakurai S, Yamamoto Y, Takiya T, Futo S, Watanabe T, Yamamoto H.

Endothelium. 2004 Sep-Dec;11(5-6):293-300.

PMID:
15763949

Supplemental Content

Loading ...
Support Center